Resultados de la búsqueda 271-280 of 9404 for Low-Dose Naltrexone
This study includes 2 parts; step-up dose optimization (Part 1) and dose expansion (Part 2). ... In Part 2, the step-up dose ... low incomes or poor access to ...
Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...
... low volume peritoneal metastasis and/or positive ... Durvalumab is FDA approved for treatment in lung cancers including non-small cell lung cancer and small cell ...
Reduced Dose Hypofractionated Radiotherapy For Indolent Non-hodgkin Lymphoma. Rochester, Minn., La Crosse, Wis., Mankato, Minn., Eau Claire, Wis ...
... dose (RP2D) for \[177Lu\]Lu FAP 2286 monotherapy ... Chemotherapy For The Treatment Of Patients With Newly Diagnosed Very Low-Risk And Low Risk Fusion Negative ...
... low incomes or poor access to transport. Studies ... dose of linvoseltamab should be used for each combination. ... This study includes 2 parts; step-up dose ...
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.
This study includes 2 parts; step-up dose optimization (Part 1) and dose expansion (Part 2). ... Small Cell Lung Cancer. Jacksonville, Fla. This ... small cell lung ...
The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...
This gene allows the T cells to recognize and possibly treat the cancer. The new modified T cells are called the IC19/1563 treatment. The dose of IC19/1563 will ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?